For Immediate Release DIMERIX PRESENTS AT ASX SMIDCAPS CONFERENCE 2026 MELBOURNE, Australia, 23 September 2026: Dimerix Limited (ASX: DXB), a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to advise that CEO and Managing Director, Dr Nina Webster,...
